单中心老年心血管病危险因素控制现状分析

目的了解老年患者心血管病危险因素控制现状。方法选择我院老年内科住院治疗的疑诊冠心病的老年患者256例,测定血糖、血脂水平,进行24h动态血压监测,根据相关指南推荐的血压、血糖及血脂达标值判断达标情况。根据冠状动脉造影结果将入选者分为冠心病组208例与非冠心病组48例,比较2组上述危险因素控制情况。结果 256例患者中,209例(81.6%)合并高血压,24h、昼间及夜间平均血压达标率分别为75.1%、82.8%和59.3%;99例(38.7%)合并糖尿病,血糖达标率70.7%;154例(60.2%)合并血脂异常,LDL-C达标率41.4%。冠心病组与非冠心病组血压、血糖达标率比较,差异无统计学意义(P>0.05),冠心病组LDL-C达标率低于非冠心病组,差异有统计学意义(38.5%vs 54.2%,P<0.05)。结论老年心血管病高危患者中,血压、血糖达标率高,LDL-C达标率较低,尤其心血管病极高危的冠心病患者LDL-C达标率更低,应重视老年患者心血管病风险评估,并进一步加强对血脂的干预力度。

Control of risk factors for senile cardiovascular diseases in a single center

Objective To study the control of risk factors for senile cardiovascular diseases.Methods Two hundred and fifty-six suspected coronary heart disease(CHD)patients were included in this study.Their blood glucose,serum lipid level and 24hambulary blood pressure were measured.Blood pressure,blood glucose and lipids were assessed according to the Japanese Society of Hypertension Guidelines for the Management of Hypertension(JSH2009),China guideline for type 2diabetes(2010)and Chinese guideline on prevention and treatment of dyclipidemia in adults(2007),respectively.The patients were divided into CHD group(n=208)and non-CHD group(n=48)according to their coronary angiography.The control of risk factors was compared between the two groups.Results Of the 256patients,81.6% were complicated with hypertension with their 24h,day and night blood pressure returned to normal in 75.1%,82.8%and 59.3%respectively after treatment,38.7% were complicated with diabetes with their blood glucose and serum LDL-C level become normal in 70.7%and 41.4%respectively after treatment.No significant difference was found in blood glucose between the two groups after treatment(P>0.05).However,the serum LDL-C level was significantly lower in CHD group than in non-CHD group(38.5%vs 54.2%,P<0.05).Conclusion The blood pressure and blood glucose are high whereas the serum LDL-C level is low in elderly patients at high risk of cardiovascular diseases,importance should thus be attached to the assessment of such diseases and the control of blood lipid level in elderly CHD patients.